The Ohio State University Sports Medicine Center and Cartilage Restoration Program and Department of Orthopaedics, The Ohio State University, Columbus, OH 43221, USA.
Arthroscopy. 2013 Mar;29(3):566-74. doi: 10.1016/j.arthro.2012.10.008. Epub 2013 Jan 8.
To compare clinical outcomes of patients undergoing isolated patellofemoral autologous chondrocyte implantation (ACI) and ACI combined with patellofemoral realignment.
A systematic review was performed by use of PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines/checklist. We searched PubMed, CINAHL (Cumulative Index to Nursing and Allied Health Literature), SportDiscus, and the Cochrane Central Register of Controlled Trials databases from 1946 through February 2012 to determine whether a difference exists in outcomes of combined ACI and osteotomy versus isolated ACI (minimum 2 years' follow-up). Studies were included only if outcomes were reported separately for both isolated ACI and combined ACI and osteotomy. All ACI generations were eligible for inclusion. Patellofemoral osteotomies eligible for inclusion were anteriorization, medialization, or anteromedialization. All patient-, limb-, and defect-specific characteristics were assessed. All reported clinical scores, radiographic and histologic outcomes, and complications/reoperations were analyzed. Risk of bias was assessed within all studies.
Eleven studies (10 Level III or IV evidence) (366 subjects) were included. Of the defects treated, 78% were located on the patella and 22% on the trochlea. The mean subject age was 33.3 years. Twenty-three percent of subjects underwent concomitant osteotomy. The mean length of follow-up was 4.2 years. Significant (P < .05) improvements in patients undergoing both isolated ACI and combined ACI and osteotomy for patellofemoral chondral defects were observed in all studies. Three studies directly compared isolated ACI and combined ACI and osteotomy, with significantly (P < .05) greater improvements shown in patients undergoing combined osteotomy and ACI (International Knee Documentation Committee subjective score, Lysholm score, Knee Injury and Osteoarthritis Outcome Score, Tegner score, modified Cincinnati score, Short Form 12 score, and Short Form 36 score). There was no significant difference between groups in the rate of postoperative complications overall.
This review showed statistically significant improvements in patients undergoing both isolated ACI and ACI combined with osteotomy for patellofemoral chondral defects in all studies. When individual studies compared these 2 groups (3 studies), significantly greater improvements in multiple clinical outcomes in subjects undergoing ACI combined with osteotomy were observed. There was no significant difference in the rate of total complications between groups.
Level IV, systematic review of studies with minimum Level IV evidence, retrospective case series.
比较单纯髌股自体软骨细胞移植(ACI)与 ACI 联合髌股排列矫正术治疗患者的临床结果。
采用 PRISMA(系统评价和荟萃分析的首选报告项目)指南/清单进行系统评价。我们检索了 PubMed、CINAHL(护理和相关健康文献累积索引)、SportDiscus 和 Cochrane 对照试验中心注册数据库,检索时间从 1946 年至 2012 年 2 月,以确定 ACI 联合截骨术与单纯 ACI(至少 2 年随访)的结果是否存在差异。只有当单独报告了单纯 ACI 和 ACI 联合截骨术的结果时,才纳入研究。所有 ACI 代次均符合纳入标准。纳入的髌股截骨术为前位化、内移化或前内移化。评估了所有患者、肢体和缺陷特异性特征。分析了所有报告的临床评分、影像学和组织学结果以及并发症/再次手术。对所有研究均进行了偏倚风险评估。
纳入 11 项研究(10 项 III 级或 IV 级证据)(366 例患者)。治疗的缺陷中,78%位于髌骨,22%位于滑车。患者平均年龄为 33.3 岁。23%的患者接受了联合截骨术。平均随访时间为 4.2 年。所有研究均观察到单纯 ACI 和 ACI 联合截骨术治疗髌股软骨缺损的患者在所有研究中均有显著(P<.05)的改善。3 项研究直接比较了单纯 ACI 和 ACI 联合截骨术,联合截骨术和 ACI 的患者改善更显著(国际膝关节文献委员会主观评分、Lysholm 评分、膝关节损伤和骨关节炎结果评分、Tegner 评分、改良辛辛那提评分、短格式 12 评分和短格式 36 评分)。总体而言,两组之间术后并发症发生率无显著差异。
本综述显示,在所有研究中,单纯 ACI 和 ACI 联合截骨术治疗髌股软骨缺损的患者均有统计学上的显著改善。当个别研究比较这两组(3 项研究)时,接受 ACI 联合截骨术的患者在多个临床结局的改善上更为显著。两组之间总的并发症发生率无显著差异。
IV 级,最低 IV 级证据的研究系统评价,回顾性病例系列。